The growth of the global point-of-care diagnostics market is attributed to the increasing occurrences of target diseases, high prevalence of infectious diseases, and growing inclination toward home healthcare, among many more. Point-of-care testing plays a vital role in the early detection of analytes near a patient, which provides a better diagnosis of, management, and monitoring of the disease. It allows in taking quick medical decisions, since the disorders could be diagnosed at an early stage, leading to overall enhanced health results. Various point-of-care diagnostics are developed, which are making way for next-generation point-of-care diagnostics. Under the point-of-care diagnostics the biosensor is the one of the most utilized components. SPR (surface plasmon resonance), electrochemical, and WLRS (white light reflectance spectroscopy), among many more, are some of the prospective label-free biosensors developed and utilized for enhanced point-of-care diagnostics.
Browse the full report of “Point-of-Care Diagnostics Market by Application (Cardiology, Diabetes, Infectious Diseases, Oncology and Other Applications), by Prescription Mode (Over-The-Counter Testing and Prescription-Based Diagnostics), by End-User (Hospital and Clinics, Home Care, and Other) – Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2019-2025” at https://www.omrglobal.com/industry-reports/point-of-care-diagnostics-market/
Technologies including system integration, lab-on-a-chip, device automation, signal readout, and microfluidic are offering the favorable results for constant enhancements in point-of-care diagnostics market. There is a rising trend for the incorporation of point-of-care diagnostics into clinical practices for facilitated treatment. The emerging need for the expansion of next-gen point-of-care diagnostic devices for the resolution of gaps in stroke clinical practices is expected to provide a substantial boost to the point-of-care diagnostics market.
Moreover, another trend in point-of-care diagnostics that could be observed is the strong inclination toward smart devices set with mobile healthcare, which is expected to revolutionize healthcare management and monitoring, consequently making way for next-gen point-of-care diagnostics. An extensive series of mobile healthcare technologies are developed, assisting the point-of-care diagnostics market. Breakthroughs in nanotechnology have provided a significant thrust to the point-of-care diagnostics market. Nanotechnology could end up giving resolution for massive headsets in VR environments.
Furthermore, demand for point-of-care diagnostics for ease in
treatments and simplistic operations, is increasing in urban area, which
is impelling the point-of-care diagnostics market growth.
On the other hand, robust government policies and regulations could
impede the market growth. Key point-of-care diagnostics service
providers include Abbott Laboratories, Inc., Nova Biomedical Corp.,
Siemens Healthcare GmbH, Becton, Dickinson, and Co., Bio-Rad
Laboratories, Inc., EKF Diagnostics Holdings PLC, among many more.
Current Market Trends Covered in the Market Report:
The Report Global Point-Of-Care Diagnostics Market Segmentation
By Application
By Prescription Mode
By End-User
By Region
North America
Europe
Asia-Pacific
Rest of the World